AI assistant
CHALICE MINING LIMITED — Director's Dealing 2013
Jun 5, 2013
64649_rns_2013-06-05_1e2f71b3-b5b9-46e5-a7c8-1d3f1e0646da.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity CHALICE GOLD MINES LIMITED ABN 47 116 648 956
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Dr Douglas Jones |
|---|---|
| Date of last notice | 18 December 2012 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct and indirect. |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. | Mrs Margaret Jones is the spouse of Dr Jones.Eburnean Superfund – Dr Jones is the trusteeand beneficiary of the Eburnean Superfund.D&M Jones Family Trust – Dr Jones is thetrustee. |
| Date of change | 5 June 2013 |
| No. of securities held prior to change | 296,278 fully paid ordinary shares.1,250,000 unlisted options with an exerciseprice of 35 cents and with an expiry date of 31March 2014.1,250,000 options with an exercise price of 45cents and with an expiry date of 31 March2014. |
| Class | Performance rights |
| Number acquired | 655,000 |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Number disposed | Nil |
|---|---|
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation | Performance Rights represent the LongTerm Incentive component of remunerationfor Dr Jones and are issued for nil cashconsideration. On vesting, one PerformanceRight is converted to one fully paid ordinaryshare in the Company. Vesting is subject toperformance and other conditions set out inthe Notice of General Meeting distributed toshareholders on 29 April 2013. |
| No. of securities held after change | 296,278 fully paid ordinary shares.1,250,000 unlisted options with an exerciseprice of 35 cents and with an expiry date of 31March 2014.1,250,000 options with an exercise price of 45cents and with an expiry date of 31 March2014.655,000 performance rights. |
| Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back | Issue of performance rights under the termsand conditions of the Company’s EmployeeLongTermIncentivePlanfollowingshareholder approval at the Company’sGeneral Meeting held on 5 June 2013. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder(if issued securities) | N/A |
| Date of change | N/A |
| No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed | N/A |
| Interest acquired | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| Interest disposed | N/A |
|---|---|
| Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation | N/A |
| Interest after change | N/A |
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? | No |
| If so, was prior written clearance provided to allow the tradeto proceed during this period? | N/A |
| If prior written clearance was provided, on what date was thisprovided? | N/A |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3